Copyright: ©Author(s) 2026.
World J Clin Cases. Jul 26, 2026; 14(21): 121907
Published online Jul 26, 2026. doi: 10.12998/wjcc.121907
Published online Jul 26, 2026. doi: 10.12998/wjcc.121907
Table 1 Correlations between serum dickkopf-1 and indices of disease activity, inflammation, and autoimmunity in rheumatoid arthritis
| Parameter | Correlation finding | Ref. |
| DKK-1 vs DAS-28 | r = 0.960 (very strong positive) | Ali et al[9], Juarez et al[54], Fang et al[55] |
| DKK-1 vs DAS-28 (Spearman) | rho = 0.75 | Abdulaziz et al[56], Coras et al[57] |
| DKK-1 vs CRP | r = 0.640 (significant positive) | Santos et al[11], Sadek et al[42], Coras et al[57] |
| DKK-1 vs ESR | r = 0.498 (significant positive) | Santos et al[11], Sadek et al[42], Coras et al[57] |
| DKK-1 vs RF | r = 0.473 (significant positive) | Ali et al[9], Santos et al[11] |
| DKK-1 vs Anti-CRP antibodies | r = 0.478 (significant positive) | Ali et al[9], Santos et al[11] |
| DKK-1 vs RA | r = 0.876 (very strong positive) | Santos et al[11] |
| DKK-1 vs steinbrocker functional grade | Higher levels in class III (4689-8092 pg/mL) | Ma et al[8], Ali et al[9], Sadek et al[42], Juarez et al[54] |
| Diagnostic cut-off | 2726.97 pg/mL; sensitivity of 98.18%, specificity of 100% for active RA by DAS-28 | Procaccia et al[58], Bagherzadeh-Fard et al[59], McWilliams et al[60], Pertsinidou et al[61] |
Table 2 Comparative roles of imaging modalities and dickkopf-1 in rheumatoid arthritis
| Parameter | Ultrasound | Radiography | MRI | DKK-1 |
| Detects early synovitis | Yes (PDUS best) | No | Yes | Indirectly |
| Detects bone marrow edema | No | No | Yes (strongest predictor) | No |
| Sensitivity in eRA | High | Low | Very high | Moderate-high |
| Predicts future damage | Yes (persistent PDUS) | Yes (if baseline erosions) | Yes (BME) | Yes (erosions, JSN) |
| Remission assessment | Subclinical synovitis | No role | Confirms deep remission | Ongoing bone injury risk |
| Correlation with DKK-1 | PDUS: ESR, CRP, DKK-1 | RF, ACPA, DKK-1 | BME: Erosive risk markers | N/A |
| Treatment monitoring | Excellent | Poor | Good (costly) | Good; falls with biologics |
| Key limitation | Operator dependent | Insensitive early disease | Cost and access | Assay variability |
- Citation: Rajesh AV, Gunasekar A, Jeyaraman N, Bharadwaj S, Nallakumarasamy A, Muthu S, Jeyaraman M. Dickkopf-1 in rheumatoid arthritis: Mechanistic insights, imaging associations, and emerging therapeutic strategies. World J Clin Cases 2026; 14(21): 121907
- URL: https://www.wjgnet.com/2307-8960/full/v14/i21/121907.htm
- DOI: https://dx.doi.org/10.12998/wjcc.121907